Literature DB >> 31834110

Monitoring Eosinophilic Esophagitis Disease Activity With Blood Eosinophil Progenitor Levels.

Anna Henderson1, Adam Magier2, Justin T Schwartz2, Lisa J Martin3,4, Margaret H Collins5,4, Philip E Putnam1,4, Vincent A Mukkada1,4, J Pablo Abonia2,4, Marc E Rothenberg2, Patricia C Fulkerson2,4.   

Abstract

OBJECTIVES: A minimally invasive biomarker to monitor disease activity is one of the greatest unmet clinical needs of the pediatric eosinophilic esophagitis (EoE) population. We aimed to determine whether circulating eosinophil progenitors (EoPs) could be used as a biomarker to identify pediatric patients with active EoE.
METHODS: In a prospective observational study, peripheral blood samples, symptom history, and laboratory data were collected from pediatric patients undergoing endoscopy for evaluation of EoE on dietary therapy at Cincinnati Children's Hospital. Peripheral blood EoP level was determined by flow cytometry.
RESULTS: Thirty-four children with active (n = 16) and inactive (n = 18) EoE were included in the analysis. EoP levels in the peripheral blood were 3-fold higher in patients with active EoE than inactive EoE (P < 0.0025). Blood absolute eosinophil count did not distinguish between active and inactive EoE (P = 0.16). A cut-off EoP level ≥17 accurately detected active disease in 79% of patients with 94.4% specificity and 62.5% sensitivity (area under the curve 0.81; P < 0.0024). Antihistamine use lowered the threshold EoP level to detect active EoE.
CONCLUSIONS: This study suggests that blood EoP levels may be used as a biomarker to detect active EoE disease in patients undergoing food trials and potentially reduce the need for repeated endoscopies. Larger prospective studies are needed to investigate the effects of antihistamines and swallowed steroids on EoP mobilization into the peripheral blood and longitudinal studies to assess the performance of the assay in individual patients over time.

Entities:  

Mesh:

Year:  2020        PMID: 31834110      PMCID: PMC7772866          DOI: 10.1097/MPG.0000000000002583

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   3.288


  26 in total

1.  An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.

Authors:  Amal H Assa'ad; Sandeep K Gupta; Margaret H Collins; Mike Thomson; Amy T Heath; Deborah A Smith; Teresa L Perschy; Cynthia H Jurgensen; Hector G Ortega; Seema S Aceves
Journal:  Gastroenterology       Date:  2011-08-09       Impact factor: 22.682

2.  Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis.

Authors:  Bridget K Butz; Ting Wen; Gerald J Gleich; Glenn T Furuta; Jonathan Spergel; Eileen King; Robert E Kramer; Margaret H Collins; Emily Stucke; Colleen Mangeot; W Daniel Jackson; Molly O'Gorman; J Pablo Abonia; Scott Pentiuk; Philip E Putnam; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2014-04-22       Impact factor: 22.682

Review 3.  Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Authors:  Evan S Dellon; Chris A Liacouras; Javier Molina-Infante; Glenn T Furuta; Jonathan M Spergel; Noam Zevit; Stuart J Spechler; Stephen E Attwood; Alex Straumann; Seema S Aceves; Jeffrey A Alexander; Dan Atkins; Nicoleta C Arva; Carine Blanchard; Peter A Bonis; Wendy M Book; Kelley E Capocelli; Mirna Chehade; Edaire Cheng; Margaret H Collins; Carla M Davis; Jorge A Dias; Carlo Di Lorenzo; Ranjan Dohil; Christophe Dupont; Gary W Falk; Cristina T Ferreira; Adam Fox; Nirmala P Gonsalves; Sandeep K Gupta; David A Katzka; Yoshikazu Kinoshita; Calies Menard-Katcher; Ellyn Kodroff; David C Metz; Stephan Miehlke; Amanda B Muir; Vincent A Mukkada; Simon Murch; Samuel Nurko; Yoshikazu Ohtsuka; Rok Orel; Alexandra Papadopoulou; Kathryn A Peterson; Hamish Philpott; Philip E Putnam; Joel E Richter; Rachel Rosen; Marc E Rothenberg; Alain Schoepfer; Melissa M Scott; Neil Shah; Javed Sheikh; Rhonda F Souza; Mary J Strobel; Nicholas J Talley; Michael F Vaezi; Yvan Vandenplas; Mario C Vieira; Marjorie M Walker; Joshua B Wechsler; Barry K Wershil; Ting Wen; Guang-Yu Yang; Ikuo Hirano; Albert J Bredenoord
Journal:  Gastroenterology       Date:  2018-09-06       Impact factor: 22.682

Review 4.  Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults.

Authors:  Alfredo J Lucendo; Javier Molina-Infante; Ángel Arias; Ulrike von Arnim; Albert J Bredenoord; Christian Bussmann; Jorge Amil Dias; Mogens Bove; Jesús González-Cervera; Helen Larsson; Stephan Miehlke; Alexandra Papadopoulou; Joaquín Rodríguez-Sánchez; Alberto Ravelli; Jukka Ronkainen; Cecilio Santander; Alain M Schoepfer; Martin A Storr; Ingrid Terreehorst; Alex Straumann; Stephen E Attwood
Journal:  United European Gastroenterol J       Date:  2017-01-23       Impact factor: 4.623

5.  Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.

Authors:  Jonathan M Spergel; Marc E Rothenberg; Margaret H Collins; Glenn T Furuta; Jonathan E Markowitz; George Fuchs; Molly A O'Gorman; Juan Pablo Abonia; James Young; Timothy Henkel; H Jeffrey Wilkins; Chris A Liacouras
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

6.  Interleukin-5 in growth and differentiation of blood eosinophil progenitors in asthma: effect of glucocorticoids.

Authors:  H P Kuo; C H Wang; H C Lin; K S Hwang; S L Liu; K F Chung
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

7.  Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects.

Authors:  R Sehmi; K Howie; D R Sutherland; W Schragge; P M O'Byrne; J A Denburg
Journal:  Am J Respir Cell Mol Biol       Date:  1996-11       Impact factor: 6.914

Review 8.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

9.  Eosinophilic Esophagitis Reference Score Accurately Identifies Disease Activity and Treatment Effects in Children.

Authors:  Joshua B Wechsler; Scott M Bolton; Katie Amsden; Barry K Wershil; Ikuo Hirano; Amir F Kagalwalla
Journal:  Clin Gastroenterol Hepatol       Date:  2017-12-15       Impact factor: 11.382

Review 10.  Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis.

Authors:  Angel Arias; Jesús González-Cervera; José M Tenias; Alfredo J Lucendo
Journal:  Gastroenterology       Date:  2014-02-15       Impact factor: 22.682

View more
  5 in total

Review 1.  Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.

Authors:  Ian F Slack; Justin T Schwartz; Vincent A Mukkada; Shawna Hottinger; J Pablo Abonia
Journal:  Curr Allergy Asthma Rep       Date:  2020-06-06       Impact factor: 4.806

Review 2.  Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.

Authors:  Dilawar Khokhar; Sahiti Marella; Gila Idelman; Joy W Chang; Mirna Chehade; Simon P Hogan
Journal:  Clin Exp Allergy       Date:  2022-07-19       Impact factor: 5.401

Review 3.  Noninvasive tests for eosinophilic esophagitis: Ready for use?

Authors:  Emily C McGowan; Seema S Aceves
Journal:  Ann Allergy Asthma Immunol       Date:  2021-10-24       Impact factor: 6.248

4.  Noninvasive biomarkers identify eosinophilic esophagitis: A prospective longitudinal study in children.

Authors:  Joshua B Wechsler; Steven J Ackerman; Mirna Chehade; Katie Amsden; Mary E Riffle; Ming-Yu Wang; Jian Du; Matt L Kleinjan; Preeth Alumkal; Elizabeth Gray; Kwang-Youn A Kim; Barry K Wershil; Amir F Kagalwalla
Journal:  Allergy       Date:  2021-05-10       Impact factor: 14.710

Review 5.  Non-invasive biomarkers of eosinophilic esophagitis.

Authors:  Martina Votto; Maria De Filippo; Riccardo Castagnoli; Francesco Delle Cave; Francesca Giffoni; Viola Santi; Marta Vergani; Carlo Caffarelli; Mara De Amici; Gian Luigi Marseglia; Amelia Licari
Journal:  Acta Biomed       Date:  2021-11-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.